Introduction
The sea cucumber Cucumaria echinata contains four Ca 2+ -dependent, Gal/GalNAc-specific lectins (CEL-I-IV) (Hatakeyama et al., 1994) . While CEL-I and CEL-IV are C-type lectins, composed of two and four C-type carbohydrate-recognition domains, respectively (Hatakeyama, Ohuchi et al., 1995; Hatakeyama et al., 2002) , CEL-III has been found to belong to the ricin (R)-type lectins, which show sequence similarities with the B-chain of ricin, a toxic plant lectin (Villafranca & Robertus, 1981; Araki & Funatsu, 1987) . CEL-III shows strong haemolytic activity towards erythrocytes as well as cytotoxicity towards some cultured cell lines (Oda et al., 1997; Hatakeyama, Nagatomo et al., 1995) . These activities manifest in target cell membranes through the formation of ion-permeable pores, composed of CEL-III oligomers inserted in the membrane (Hatakeyama et al., 1996; Kouzuma et al., 2003; Kouriki-Nagatomo et al., 1999) . The crystal structure of CEL-III monomer has been solved (Uchida et al., 2004; PDB entry 1vcl) and it was found to be composed of three domains, in which domains 1 and 2 have -trefoil folds containing the QXW (Gln-X-Trp) motif (Hazes, 1996) in their carbohydrate-binding sites (Hatakeyama et al., 2007 ; PDB entries 2z48 and 2z49), resembling the B-chain of ricin. Domain 3 possesses a unique fold, composed of long -strands and two -helices. These -helices are accommodated in a cleft formed between domains 1 and 2, stabilizing the association between these domains and domain 3. Previous studies have suggested that binding of CEL-III to the cell surface carbohydrate chains via its domains 1 and 2 triggers an extensive conformational change in domain 3, leading to its oligomerization (Kouzuma et al., 2003) . The hydrophobic region in domain 3, including two -helices H8 and H9 (residues 320-354), is supposed to play an important role in such an oligomerization process (Hisamatsu et al., 2008 (Hisamatsu et al., , 2009 .
While CEL-III forms oligomers composed of hexamers or heptamers in cell membranes during haemolytic action, structures of similar size have also been found to form in solution under conditions of high pH and high salt concentration, in which the protein-bound disaccharides contain -galactoside structures, such as lactose (Gal1-4Glc) and lactulose (Gal1-4Fru) (Hatakeyama et al., 1996; Kuwahara et al., 2002) . This finding suggests that the oligomerization # 2013 International Union of Crystallography All rights reserved electronic reprint process is triggered by binding to -galactoside-containing carbohydrate chains on the cell surface and is further promoted by a hydrophobic environment on cell membrane surfaces. It appears likely that high salt concentration and high pH conditions facilitate conformational changes of domain 3 in place of the hydrophobic environment on the cell membrane.
For elucidation of CEL-III's haemolytic mechanism, crystals of CEL-III oligomers, formed in erythrocyte membranes as well as in solution, were prepared and preliminary crystallographic analyses performed.
Materials and methods

Purification and oligomerization of CEL-III
CEL-III was extracted from the body fluid of C. echinata and purified by affinity column chromatography using lactose-Cellulofine and GalNAc-Cellulofine columns, followed by a gel-filtration column, as previously reported (Hatakeyama et al., 1996) .
Soluble CEL-III oligomer was prepared essentially as previously described (Hatakeyama et al., 1996) . Briefly, CEL-III (2 mg ml À1 ) was incubated in the presence of 1 M NaCl, 0.1 M glycine-NaOH pH 10, 0.01 M CaCl 2 , 0.1 M lactulose at 298 K for 2 h. As X-ray scattering analyses have shown that the resulting CEL-III oligomers, composed of six or seven monomers, mostly associate as core oligomers to produce larger formations of $21-mer with relatively weak interactions (Fujisawa et al., 1997) , they were then treated with 0.1% of n-dodecyl--d-maltoside (DDM), to force dissociation into core oligomers, and dialysed against 0.01 M Tris-HCl pH 7.6, 0.15 M NaCl. The CEL-III oligomers were next concentrated to 12 mg ml À1 using a 100 kDa cutoff ultrafiltration membrane (Vivaspin, GE Healthcare Bio-Sciences AB, Uppsala, Sweden) and stabilized by dialysis against 0.01 M Tris-HCl pH 7.6, 0.15 M NaCl, 0.01 M CaCl 2 , 0.1 M lactulose, 0.5% DDM at 293 K for 1 h.
Membrane oligomers were prepared from the oligomers formed in erythrocyte membranes by treatment with CEL-III. For this, CEL-III was incubated with rabbit erythrocyte suspension [10%(v/v)] in 0.01 M Tris-HCl pH 7.5, 0.15 M NaCl, 0.01 M CaCl 2 at 277 K for 1 h for cell lysis. After centrifugation of the resulting suspension, the pelleted membrane fraction was washed three times with 0.01 M TrisHCl pH 7.5, 0.15 M NaCl by centrifugation and then solubilized with 2%(v/v) of Triton X-100 in 0.01 M Tris-HCl pH 7.5, 0.15 M NaCl at 277 K for 1 h. After another centrifugation, solubilized oligomers were purified on a lactose-Cellulofine column in 0.01 M Tris-HCl pH 7.5, 0.15 M NaCl, 0.03%(v/v) DDM.
Crystallization of CEL-III oligomers
Purified CEL-III oligomers were crystallized using a sitting-drop vapour-diffusion method. The initial screening for crystallization of the soluble oligomer was done using the screening kits Crystal Screen, Crystal Screen 2 (Hampton Research, Aliso Viejo, California, USA) and Wizard I and II (Emerald BioSystems, Inc., Bedford, Massachusetts, USA). In the initial screening of crystallization, 1 ml of protein solution (10 mg ml À1 ) in buffer consisting of 0.01 M Tris-HCl pH 7.6, 0.15 M NaCl, 0.01 M CaCl 2 , 0.1 M lactulose, 0.5%(v/v) DDM was mixed with an equal volume of reservoir solution and allowed to equilibrate against 100 ml of the reservoir solution at 293 K. As crystals could be obtained under several variable conditions, crystallization was optimized by employing various solution volumes, precipitant concentrations and pH levels.
Initial screening for crystallization of the membrane oligomer was carried out using the above screening kits in the presence of DDM. Here, 1 ml of the membrane oligomer solution in 0.01 M Tris-HCl pH 7.5, 0.15 M NaCl containing 0.01 M CaCl 2 and 0.1 M lactose was mixed with an equal volume of the reservoir solution containing 0.03%(v/v) DDM and allowed to equilibrate against 0.3 ml of reservoir solution at 293 K. Crystals of the soluble oligomer (a) and the membrane oligomer (b) of CEL-III. 
Data collection and processing
Data collection from CEL-III oligomer crystals was performed on beamline BL5A of the Photon Factory at the High Energy Acceleration Research Organization (Tsukuba, Japan), using an ADSC Quantum 210r and 315r CCD detector (Area Detector Systems Corp., Poway, California, USA). Image data were processed using the HKL-2000 program (Otwinowski & Minor, 1997) .
Results and discussion
Crystallization of CEL-III oligomers and data collection
Rhomboid crystals of the soluble oligomer (Fig. 1a) were obtained using a reservoir solution consisting of 30%(v/v) PEG 400, 0.1 M CdCl 2 , 0.1 M sodium acetate pH 4.6. After condition optimization, 4-6 ml of protein solution (10 mg ml X-ray diffraction data were collected using synchrotron radiation on beamline BL5A at the Photon Factory. Crystals of the soluble oligomer diffracted to 3.3 Å resolution (Fig. 2a) , while those of the membrane oligomer diffracted to 4.2 Å resolution (Fig. 2b) . Although the processing of membrane oligomer crystal diffraction data was not successful because of poor-quality results, those of the soluble oligomer were successfully analysed. Data statistics for the soluble oligomer crystal are summarized in Table 1 , with the space group determined to be monoclinic C2 and unit-cell parameters of a = 218. 3, b = 230.7, c = 133.6 Å , = 126.9 . A self-rotation function was computed, using the MOLREP program (Vagin & Teplyakov, 2010) from the CCP4 program suite (Winn et al., 2011) , to obtain information on the oligomer's quaternary structure (Fig. 3) . The results showed a single peak at the same position in each of the sections of = 51. 8, 103.0 and 154.6 , and seven peaks in the section of = 180
. The peaks in the sections of = 51.8, 103.0 and 154.6 nearly corresponded to a sevenfold axis, and the peak in the section of = 180 corresponded to seven twofold axes located perpendicular to the sevenfold axis. These symmetric properties suggested that the oligomer formed a heptameric ring-like shape including one sevenfold axis and seven pseudo-twofold axes perpendicular to the sevenfold axis. Pore-forming oligomers of several bacterial toxins are known to be heptamers, such as in Staphylococcus aureus -haemolysin (Song et al., 1996) , protective antigen of anthrax toxin from Bacillus anthracis (Lacy et al., 2004) and cytolysin from Vibrio cholerae (De & Olson, 2011) . The sevenfold rotation symmetry found in the present CEL-III oligomer crystal might also have been an indication of heptameric structure. Although it is still unclear whether the membrane oligomer possessed an oligomeric structure similar to the soluble oligomer, their similar sizes on SDS-PAGE (Hatakeyama et al., 1996; Kuwahara et al., 2002) strongly suggest that they shared almost identical oligomeric structures. The differences in the diffraction patterns of the soluble and membrane oligomers would have been due to differences in their preparation conditions. It is also possible that some membrane lipids, including glycolipids, that originated from erythrocytes may have remained bound to the membrane oligomer and thus affected the crystallization conditions and quality of the diffractions. Further analyses of CEL-III oligomer crystals are in progress. Figure 3 Self-rotation function peaks calculated by MOLREP. Sections of = 51. 8, 103.0, 154.6 and 180.0 shown.
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